Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: West Nile virus (WNV) is the leading cause of mosquito-borne illness in the continental USA. WNV occurrence has high spatiotemporal variation, and current approaches to targeted control of the virus are limited, making forecasting a public health priority. However, little research has been done to compare strengths and weaknesses of WNV disease forecasting approaches on the national scale. We used forecasts submitted to the 2020 WNV Forecasting Challenge, an open challenge organized by the Centers for Disease Control and Prevention, to assess the status of WNV neuroinvasive disease (WNND) prediction and identify avenues for improvement.

Methods: We performed a multi-model comparative assessment of probabilistic forecasts submitted by 15 teams for annual WNND cases in US counties for 2020 and assessed forecast accuracy, calibration, and discriminatory power. In the evaluation, we included forecasts produced by comparison models of varying complexity as benchmarks of forecast performance. We also used regression analysis to identify modeling approaches and contextual factors that were associated with forecast skill.

Results: Simple models based on historical WNND cases generally scored better than more complex models and combined higher discriminatory power with better calibration of uncertainty. Forecast skill improved across updated forecast submissions submitted during the 2020 season. Among models using additional data, inclusion of climate or human demographic data was associated with higher skill, while inclusion of mosquito or land use data was associated with lower skill. We also identified population size, extreme minimum winter temperature, and interannual variation in WNND cases as county-level characteristics associated with variation in forecast skill.

Conclusions: Historical WNND cases were strong predictors of future cases with minimal increase in skill achieved by models that included other factors. Although opportunities might exist to specifically improve predictions for areas with large populations and low or high winter temperatures, areas with high case-count variability are intrinsically more difficult to predict. Also, the prediction of outbreaks, which are outliers relative to typical case numbers, remains difficult. Further improvements to prediction could be obtained with improved calibration of forecast uncertainty and access to real-time data streams (e.g. current weather and preliminary human cases).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834680PMC
http://dx.doi.org/10.1186/s13071-022-05630-yDOI Listing

Publication Analysis

Top Keywords

wnnd cases
16
forecasting challenge
8
west nile
8
nile virus
8
neuroinvasive disease
8
forecasts submitted
8
submitted 2020
8
discriminatory power
8
historical wnnd
8
data associated
8

Similar Publications

Detection of autoantibodies against Interferon Type I in patients with autochthonous West Nile Virus encephalitis.

Brain Behav Immun Health

October 2025

Department of Medicine I (Gastroenterology, Rheumatology, Infectious Diseases), Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.

West Nile virus (WNV) is a neurotropic flavivirus that has become a global concern because of its rapid geographical spread and its capacity to cause severe disease in humans. Although often asymptomatic, infection can lead to life-threatening neuroinvasive disease (WNND) in a small percentage of cases, particularly among elderly individuals and individuals with compromised immune responses. We present three cases of autochthonous WNND from Germany from 2023 to 2024, which showcase various neurological manifestations and their correlation with immune responses.

View Article and Find Full Text PDF

Background And Objectives: The literature on severe West Nile virus (WNV) neuroinvasive disease (WNND) in patients treated with anti-CD20 therapies is limited. We systematically characterize cases of WNND in the tertiary academic UCHealth system.

Methods: A retrospective cohort (January 2016 to January 2024) of patients with a validated diagnosis of WNND and anti-CD20 medication use was identified with electronic medical record query followed by individual chart review.

View Article and Find Full Text PDF

Characteristics and clinical outcomes of the West Nile virus outbreak in Israel 2024: A retrospective cohort study.

Diagn Microbiol Infect Dis

October 2025

Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tikva 49100, Israel; Faculty of Medicine & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel; Infectious Disease Unit, Rabin Medical Center, Beilinson Campus, Petah-Tikva 49100, Israel.

Background: In 2024, Israel experienced its largest West Nile virus (WNV) outbreak in two decades, with over 930 cases and 72 deaths, revealing unique epidemiological patterns.

Aim: To describe the clinical features, outcomes, and risk factors for poor hospitalization outcomes in patients with WNV infection during this outbreak.

Methods: A retrospective cohort study of WNV-infected patients admitted to Rabin Medical Center (RMC) during the year 2024.

View Article and Find Full Text PDF

Epidemiology of West Nile Virus in New York City: Trends and Transmission Dynamics (2000-2019).

Pathogens

April 2025

Department of Health and Mental Hygiene, New York City, 125 Worth Street, Manhattan, NY 10013, USA.

The 1999 outbreak of West Nile virus (WNV) in New York City (NYC) marked the first documented introduction of the virus into the western hemisphere, prompting extensive public health surveillance. This study examines the epidemiology of WNV from 2000 to 2019, analyzing 381 human cases, including 66 cases of West Nile Fever (WNF) and 315 cases of West Nile Neuroinvasive Disease (WNND), with 35 fatalities. Simultaneously, 6632 WNV-positive mosquito pools were identified across 16 species.

View Article and Find Full Text PDF

Background: West Nile virus (WNV) is the most common cause of mosquito-borne disease in the continental USA, with an average of ~1200 severe, neuroinvasive cases reported annually from 2005 to 2021 (range 386-2873). Despite this burden, efforts to forecast WNV disease to inform public health measures to reduce disease incidence have had limited success. Here, we analyze forecasts submitted to the 2022 WNV Forecasting Challenge, a follow-up to the 2020 WNV Forecasting Challenge.

View Article and Find Full Text PDF